FDA action counts
| Total FDA actions | 1 |
|---|---|
| Warning letters | 1 |
| Recalls | 0 |
| Approval records | 0 |
| Form 483 inspection citations | 0 |
| Most recent action | June 8, 2026 |
Enforcement history
On 2026-06-08, Argus HQ recorded an FDA Warning Letter for Nexlife Inc. dba Nexlife, rated "critical" severity in Argus HQ's classification: Nexlife Inc. dba Nexlife — False & Misleading Claims/Misbranded (Telehealth) (2026-06-08). Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.
Risk pattern analysis
Argus HQ analysis — not an FDA finding
This section is Argus HQ analysis, not an FDA finding. Nexlife Inc. dba Nexlife has 1 FDA event on file. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
Frequently asked questions
- How many FDA actions has Nexlife Inc. dba Nexlife had?
- Argus HQ has recorded 1 FDA events for Nexlife Inc. dba Nexlife: 1 warning letters, 0 recalls, 0 approvals, and 0 Form 483 inspection observations. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
- What is the most recent FDA action against Nexlife Inc. dba Nexlife?
- The most recent FDA event Argus HQ has on file for Nexlife Inc. dba Nexlife is dated 2026-06-08, with a severity rating of "critical" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
- Does Argus HQ track new FDA actions for Nexlife Inc. dba Nexlife automatically?
- Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Nexlife Inc. dba Nexlife is observed, this page's event count and history update automatically.
- How many FDA actions does Argus HQ track for Nexlife Inc. dba Nexlife?
- 1 total: 1 warning letter, 0 recalls, 0 approval records, and 0 Form 483 inspection citations.
Every FDA action tied to this company, the week it happens.
Free weekly briefing. Real-time alerts on paid plans.
Related enforcement actions
Compare with
Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). Nexlife Inc. dba Nexlife's Complete FDA Record. Digital Empire LLC. Retrieved from https://argushq.ai/company/nexlife-inc-dba-nexlife
"Nexlife Inc. dba Nexlife's Complete FDA Record." Argus HQ Research, Digital Empire LLC, 2026, argushq.ai/company/nexlife-inc-dba-nexlife.
Argus HQ Research. "Nexlife Inc. dba Nexlife's Complete FDA Record." Digital Empire LLC. Accessed July 13, 2026. https://argushq.ai/company/nexlife-inc-dba-nexlife.
@misc{argushq_argushq_ai_company_nexlife_inc_dba_nexlife_2026,
title = {Nexlife Inc. dba Nexlife's Complete FDA Record},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire LLC},
url = {https://argushq.ai/company/nexlife-inc-dba-nexlife},
note = {Accessed: July 13, 2026}
}Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗